SCHEMBL6022907

SCHEMBL6022907

CCCCCCOc1cc(/C=C/C(=O)O)cc(OCCCCCC)c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.59
PTGS1 P23219 1/20 0.59
PTGS2 P35354 1/20 0.59
KDM4E B2RXH2 4/20 0.54
ACHE P22303 4/20 0.52
GAA P10253 2/20 0.50
ALOX5 P09917 1/20 0.50
KMT2A Q03164 1/20 0.50
AKR1C3 P42330 1/20 0.49
POLB P06746 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTR1A P08908 1/20 0.48
HPGD P15428 1/20 0.48
HTR2C P28335 1/20 0.48
HSD17B10 Q99714 1/20 0.48
APP P05067 3/20 0.47
LTB4R Q15722 1/20 0.46
HCAR2 Q8TDS4 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022913 1.00 PKM (0.59) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023150 1.00 PKM (0.59) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023153 1.00 PKM (0.59) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023916 0.94 PKM (0.62) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023949 0.94 PKM (0.62) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023509 0.90 KDM4E (0.66) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6023513 0.90 KDM4E (0.66) PKMPTGS1PTGS2KDM4EACHE
SCHEMBL6513271 0.84 KDM4E (0.71) KDM4EACHEGAAKMT2AAKR1C3
SCHEMBL29375709 0.84 KDM4E (0.71) KDM4EACHEGAAKMT2AAKR1C3
SCHEMBL28386561 0.84 KDM4E (0.71) KDM4EACHEGAAKMT2AAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 PKM 4160/4885PTGS1 1284/4885PTGS2 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.